Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer

Clinical trial NCT02163733 · COMPLETED

Trial details

NCT number

NCT02163733

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2014-11-14

Primary completion

2015-03-24

Enrollment

38

View on ClinicalTrials.gov